GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Telo Genomics Corp (OTCPK:TDSGF) » Definitions » Total Assets

Telo Genomics (Telo Genomics) Total Assets

: $1.14 Mil (As of Dec. 2023)
View and export this data going back to 2016. Start your Free Trial

Telo Genomics's Total Assets for the quarter that ended in Dec. 2023 was $1.14 Mil.

During the past 12 months, Telo Genomics's average Total Assets Growth Rate was 9.40% per year. During the past 3 years, the average Total Assets Growth Rate was 0.70% per year. During the past 5 years, the average Total Assets Growth Rate was -9.90% per year. During the past 10 years, the average Total Assets Growth Rate was 40.90% per year.

During the past 12 years, Telo Genomics's highest 3-Year average Total Assets Growth Rate was 520.70%. The lowest was -49.40%. And the median was -4.70%.

Total Assets is connected with ROA %. Telo Genomics's annualized ROA % for the quarter that ended in Dec. 2023 was -179.96%. Total Assets is also linked to Revenue through Asset Turnover. Telo Genomics's Asset Turnover for the quarter that ended in Dec. 2023 was 0.00.

Telo Genomics Total Assets Historical Data

The historical data trend for Telo Genomics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telo Genomics Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Total Assets
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.86 3.14 2.21 2.20

Telo Genomics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Assets Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.20 0.72 2.20 1.63 1.14

Telo Genomics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Telo Genomics's Total Assets for the fiscal year that ended in Jun. 2023 is calculated as

Total Assets=Total Equity (A: Jun. 2023 )+Total Liabilities (A: Jun. 2023 )
=1.967+0.236
=2.20

Telo Genomics's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (Q: Dec. 2023 )+Total Liabilities (Q: Dec. 2023 )
=0.899+0.239
=1.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Telo Genomics  (OTCPK:TDSGF) Total Assets Explanation

Total Assets is connected with ROA %.

Telo Genomics's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=-2.488/( (1.627+1.138)/ 2 )
=-2.488/1.3825
=-179.96 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Telo Genomics's Asset Turnover for the quarter that ended in Dec. 2023 is

Asset Turnover
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=0/( (1.627+1.138)/ 2 )
=0/1.3825
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Telo Genomics Total Assets Related Terms

Thank you for viewing the detailed overview of Telo Genomics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Telo Genomics (Telo Genomics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Telo Genomics Corp (OTCPK:TDSGF) » Definitions » Total Assets
Comparable Companies
XCNQ:SONA TSXV:AVCR XCNQ:IZO XCNQ:BUX TSXV:ARC TSX:SZLS TSXV:JUMP XCNQ:VTAL NEOE:MEDV TSXV:MBI.H TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
3D0A:Germany TELO:Canada
Address
101 College Street, Suite 200, MaRS Centre, South Tower, Toronto, ON, CAN, M5G 1L7
Website
https://www.telodx.com
Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in the development and commercialization of diagnostic and prognostic products. The company is developing diagnostic and prognostic products for cancer and neurological disorders.